Beranda › Dermatitis Atopik (Eksim)
Uji klinis Dermatitis Atopik (Eksim) yang merekrut di AS
62 studi untuk Dermatitis Atopik (Eksim) merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY13 studi
- Washington, DC11 studi
- Los Angeles, CA11 studi
- San Diego, CA10 studi
- San Antonio, TX10 studi
- Birmingham, AL9 studi
- Miami, FL9 studi
- Troy, MI8 studi
- Dallas, TX8 studi
- Sacramento, CA8 studi
- Huntington Beach, CA8 studi
- Pittsburgh, PA7 studi
- Indianapolis, IN7 studi
- Tampa, FL7 studi
- Santa Clarita, CA6 studi
- Sugar Land, TX6 studi
- Phoenix, AZ6 studi
- Santa Monica, CA6 studi
- Chicago, IL6 studi
- Philadelphia, PA6 studi
- Las Vegas, NV5 studi
- St. Petersburg, FL5 studi
- Charleston, SC5 studi
- Portland, OR5 studi
- Little Rock, AR5 studi
- Miami Gardens, FL4 studi
- Fremont, CA4 studi
- Portsmouth, NH4 studi
- Fargo, ND4 studi
- Ann Arbor, MI4 studi
- Baltimore, MD4 studi
- Louisville, KY4 studi
- Newton, MA4 studi
- Arlington, TX4 studi
- San Francisco, CA4 studi
- Coral Springs, FL4 studi
- Harrisburg, PA4 studi
- Cleveland, OH4 studi
- Morgantown, WV4 studi
- Spartanburg, SC3 studi
Berdasarkan negara bagian
- Alabama9 studi
- Arizona7 studi
- Arkansas8 studi
- California30 studi
- Colorado4 studi
- Florida18 studi
- Georgia9 studi
- Idaho4 studi
- Illinois10 studi
- Indiana9 studi
- Kentucky4 studi
- Maryland16 studi
- Massachusetts6 studi
- Michigan14 studi
- Missouri7 studi
- Nebraska4 studi
- Nevada6 studi
- New Hampshire5 studi
- New Jersey3 studi
- New York16 studi
- North Carolina8 studi
- North Dakota4 studi
- Ohio10 studi
- Oregon6 studi
- Pennsylvania13 studi
- South Carolina10 studi
- Texas18 studi
- Utah4 studi
- Virginia5 studi
- Washington3 studi
- West Virginia4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
Menerima pesertaFase 1
Usia 12 hingga 120 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07262983This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07290803A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 72 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06808477Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06947993Effects of Treatments on Atopic Dermatitis
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 2 hingga 50 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01631617A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Menerima pesertaFase 3
Usia 2 hingga 11 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06807281First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07527923Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07003425Natural History and Genetics of Food Allergy and Related Conditions
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Day – 99 Years · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02504853Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04864886Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00605878Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Menerima pesertaStudi observasional
Usia 12 hingga 89 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07645820The Impact of Dietary Salt on the Severity of Eczema
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07447063The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07487831Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Menerima peserta
Usia 13 hingga 17 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07746427A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07765888A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07223697A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Menerima pesertaFase 2/3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07355075A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599813Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
Menerima pesertaFase 2
Usia 3 hingga 21 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT03835767CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT04504955Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06899204Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.